TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer

NCT01108042 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Oropharynx Cancer
Squamous Cell Carcinoma of the Oral Cavity

Interventions

DRUG: Taxotere, Cisplatin, 5-Fluorouracil (5-FU)

Sponsor

Orlando Guntinas-Lichius, Prof. Dr. med.